Replies to post #1697 on Tetraphase Pharmaceuticals, Inc. (TTPH)

[Schnauzer1]

HI Xena, The new P3 for interabdominal infection is expected to take around 12 months. I have not seen any announcement that it has started. That might be reason for the loss of market value, and certainly supports a question mark about the ability of current leadership to manage this process. A second P3 for cUTI is also to be conducted but it also has not launched. Just wonder if anyone is steering this ship. Assuming a start today I would expect value returning to the company in about 12 months! That would put us at about this time next year.